Log In
Print
BCIQ
Print
Print this Print this
 

NMRC-M3V-Ad-PfCA malaria vaccine (Malaria vaccine)

  Manage Alerts
Collapse Summary General Information
Company GenVec Inc.
DescriptionTwo combined recombinant adenovectors expressing Plasmodium falciparum circumsporozoite (CS) protein (CSP) and apical membrane antigen 1 (AMA1) antigens
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationMalaria
Indication DetailsPrevent malaria; Prevent malaria infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today